Caenorhabditis elegans as a model system for Parkinson's disease

被引:30
|
作者
Schmidt, Enrico
Seifert, Mark
Baumeister, Ralf
机构
[1] Univ Freiburg, Bioinformat & Mol Genet Fac Biol, Ctr Biochem & Mol Cell Res, Fac Med, DE-79104 Freiburg, Germany
[2] Univ Freiburg, Freiburg Ctr Syst Biol, ZBSA, DE-79104 Freiburg, Germany
关键词
Caenorhabditis elegans; dopaminergic system; Parkinson's disease; endoplasmic reticulum stress; oxidative stress;
D O I
10.1159/000101845
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is one of the most common age-related neuroclegenerative diseases that is characterized by selective loss of dopaminergic neurons. Despite recent findings from mammalian model systems, molecular mechanisms of the pathophysiology are poorly understood. Given the high conservation of molecular pathways from invertebrates to mammalians, combined with technical advantages, such as high-throughput approaches, Caenorhabditis elegans represents a powerful system for the identification of factors involved in neurodegeneration. In this review we describe that C elegans can be used to advance our understanding of the genetic mechanisms implicated in these disorders.
引用
收藏
页码:199 / 217
页数:19
相关论文
共 50 条
  • [1] Protective effects of baicalin in a Caenorhabditis elegans model of Parkinson's disease
    Ma, Jing
    Wang, Ranran
    Chen, Ting
    Jiang, Shaowei
    Xu, Ajing
    TOXICOLOGY RESEARCH, 2021, 10 (03) : 409 - 417
  • [2] Exploring Caenorhabditis elegans as Parkinson’s Disease Model: Neurotoxins and Genetic Implications
    Larissa Pereira Dantas da Silva
    Erika da Cruz Guedes
    Isabel Cristina Oliveira Fernandes
    Lucas Aleixo Leal Pedroza
    Gustavo José da Silva Pereira
    Priscila Gubert
    Neurotoxicity Research, 2024, 42
  • [3] Exploring Caenorhabditis elegans as Parkinson's Disease Model: Neurotoxins and Genetic Implications
    da Silva, Larissa Pereira Dantas
    Guedes, Erika da Cruz
    Fernandes, Isabel Cristina Oliveira
    Pedroza, Lucas Aleixo Leal
    Pereira, Gustavo Jose da Silva
    Gubert, Priscila
    NEUROTOXICITY RESEARCH, 2024, 42 (01)
  • [4] Using a Caenorhabditis elegans Parkinson's Disease Model to Assess Disease Progression and Therapy Efficiency
    Hughes, Samantha
    van Dop, Maritza
    Kolsters, Nikki
    van de Klashorst, David
    Pogosova, Anastasia
    Rijs, Anouk M.
    PHARMACEUTICALS, 2022, 15 (05)
  • [5] Nicotine-mediated therapy for Parkinson's disease in transgenic Caenorhabditis elegans model
    Ullah, Inam
    Zhao, Longhe
    Uddin, Shahab
    Zhou, Yangtao
    Wang, Xin
    Li, Hongyu
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [6] VPS41-mediated neuroprotection in a Caenorhabditis elegans model of Parkinson's disease
    Tyson, Trevor
    Brundin, Patrik
    CURRENT DRUG SAFETY, 2012, 7 (03) : 255 - 258
  • [7] Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's disease
    Chege, Patricia M.
    McColl, Gawain
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [8] VPS41-mediated neuroprotection in a Caenorhabditis elegans model of Parkinson's disease
    Tyson, Trevor
    Brundin, Patrik
    FUTURE NEUROLOGY, 2012, 7 (03) : 255 - 258
  • [10] Perspectives on Caenorhabditis elegans models of human Parkinson's Disease
    Rudgalvyte, Martina
    Wong, Garry
    ADMET AND DMPK, 2015, 3 (02): : 122 - 130